主要業務在中國從事
提供醫療服務

Corporate Overview

Good Fellow Healthcare Holdings Limited (8143.HK) is a Hong Kong listed investment holding group company, which is committed to Hong Kong listed companies engaged in medical investment and hospital management in Mainland China and overseas. Through the capital leverage, Good Fellow Healthcare Holdings Limited actively introduces foreign advanced medical technology, management mode and service concept, combines the development status of domestic medical industry, and provides a diversified hospital operation management solution for the market through various channels such as merger and acquisition cooperation, management consultation, special items planning, professional training and entrusted management. It determined to build Good Fellow Healthcare into the preferred brand for hospital operation and management in China.

With the advantages and resources of listed companies, Good Fellow Healthcare Holdings Limited has directly invested in medical technology research and development, hospital integration and construction, and various medical services through mergers and acquisitions, cooperation, custody, franchising, and new construction, etc., in the early stage of development. On the basis of operating a comprehensive domestic secondary hospital, it formed a unique medical specialist technology and apply it to a chain of national medical institutions with distinctive characteristics to build a competitive medical service industry network to maximize the satisfaction of the domestic public on different needs of the service.

Good Fellow Healthcare hopes to have a certain number of comprehensive secondary hospitals and specialist chain hospitals in the future, and build into the group‘s main industrial platform, complete the layout of domestic medical chain institutions, and play an important role in China‘s medical and health industry. Good Fellow Healthcare has already established a strategic partnership with many medical colleges, scientific research institutions and medical service institutions inside China and abroad, and also had set up a team of experts from academic disciplines in the United States, Britain, Canada, Hong Kong, Taiwan, Beijing, Shanghai and other countries and regions. A team of experts led by the leaders can provide technical support for difficult disease consultation, surgery, etc. at any time for its medical institutions. At the same time, it will carry out leading-edge basic and clinical medical research, forming a competitive intellectual property rights and distinctive service models in the medical industry, and guarantee the long-term sustainable development of Good Fellow Healthcare.

The success and rapid development of Good Fellow Healthcare is based on its professional management team and dedicated employees. The company‘s management team consists of professionals who have long been engaged in the medical service industry in China and abroad, and professionals who have rich management experience. They have a broad international vision and a wide range of connections with medical industry and government. Under the leadership of the Group‘s Board of Directors, the company‘s management has fully demonstrated its level of M&A and operation managemen, especially in the field of integrating domestic M&A hospitals, which has shown the admirable skills and vision to ensure the continued rapid development of Good Fellow Healthcare.

At present, Good Fellow Healthcare’s medical institutions have hundreds of experts and special talents with authoritative status in various major medical technology fields. Its medical technology level and humanized service concept have formed a unique brand in the hospital location, and the hospital continues to develop an indispensable support and motivation.

Good Fellow Healthcare has formed a distinctive “Good Fellow Model” in China’s medical industry through strong capital leverage coupled with advanced hospital management experience, accurate hospital service positioning, effective cost control and advanced management experience. “Adapting to the current national conditions of China’s medical and healthcare development, it recognized by the industry, the market and the government, and become a replicable, developable and scalable specimen of the Group, truly achieving a healthy expansion of capital and at the same time developing the medical and health care industry in China.” And enhance the contribution.

Adhering to the Good Fellow civilization, Good Fellow Healthcare is committed to the development and dedication of China’s medical and health undertakings with the strong capital leverage of listed companies,advanced medical technology and management experience.

Board Member

Mr. Ng Chi Lung, Chairman

has 7 years of experience in founding new business and commercial management. Mr. Ng studied at Macquarie University (major in accounting) in Australia after obtained his diploma from the Sydney Institute of Business and Technology in year of 2008. Since February 2012, Mr. Ng founded and managed businesses including the scope of manufacturing and services sector. He was an executive director of Yueshou Environmental Holdings Limited (currently known as China Gem Holdings Limited) (stock code: 1191), the shares of which are listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), from 19 September 2014 to 1 April 2016. Mr. Ng was an executive director and vice chairman of Theme International Holdings Limited (stock code: 990) from 1 April 2016 to 31 July 2018, the shares of which are listed on the Main Board of the Stock Exchange. With effect from 23 July 2018, Mr. Ng has been appointed as an executive Director and the chairman of the Board.

Mr. Wu Qiyou, Executive Director

Mr. Wu, possesses profound expertise in business management, strateg ic planning and risk management. Mr. Wu obtained a Bachelor of Business (Banking and Finance) from the Monash University in 2016 and a Master of Business Administration from the same university in 2022. From 2016 to 2020, Mr. Wu served as an investment man ager at Cornerstone Capital Investment Group Pty Ltd, leading multiple commercial real estate projects involving retirement and medical assets, monitoring compliance and conducting risk control for those projects. From 2021 to 2022, Mr. Wu was a member of the management team at Lunghealth Medtech Company Limited, spearheading the strategic rollout of the magnetic navigation bronchoscope system in the Chinese market, ensuring the safety of the product and overseeing the compliance with the relevant laws and regulations. In December 2022, Mr. Wu founded Dynamiq Advisory Pte Ltd (“ Dynamic Advisory ”) and has been the chief executive officer Dynamic Advisory thereafter, providing its clients with comprehensive corporate services, including but not limited to comp liance and risk management services.

Ms. Wong Ka Wai, Independent Non-Executive Director

Was appointed as an independent non-executive director on 1 November 2007. Ms. Wong has over 30 years of experience in finance, accounting, taxation and corporate affairs. She is a member of the Institute of Chartered Accountants in Australia and a Certified Public Accountant of the Hong Kong Institute of Certified Public Accountants. Ms. Wong holds a bachelor degree in economics from the University of Sydney, Australia and she is currently the Chief Financial Officer of Pang & Associates, a law firm in Hong Kong and the Managing Director of a private company providing consulting and management services.

Mr. Lau Tak Kei Arthur, Independent Non-Executive Director

obtained a bachelor degree of laws from The London School of Economics and Political Science and a master of economics from The University of Hong Kong. He is licenced to carry out Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the “SFO”). Mr. Lau has over 15 years of experience spanning hedge fund, private equity and investment banking in Asia.

Hong kong HQ

Address: Unit 3309, 33/F., West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong China

Tel: +852 2722 4388

Fax: +852 2543 8865